+34 934 464 700
Quote
()
search
clear
Contact
Antibodies
Immunoassays
Cell Culture
Molecular Biology Reagents
Plastic Labware
All Categories
Home
Antibodies
Tifcemalimab
Tifcemalimab
Tax included
Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer.
Product Details
Brand:
MedChemExpress
Reference:
HY-P99961
Data sheet
Size
Multiple sizes
Reactivity
CD28
Application
Cancer-programmed cell death
Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer.
check_circle
check_circle